Train to investigate how medicines affect populations using rigorous pharmacoepidemiologic methods. This PhD option develops research skills in study design, causal inference, and real-world evidence to evaluate benefits and harms of drugs.
The Doctor of Philosophy (PhD) program in Epidemiology with a specialization in Pharmacoepidemiology at McGill University trains students to explore the effects of medicines on populations. This rigorous program emphasizes advanced research methodologies, enabling graduates to critically evaluate the benefits and risks associated with drug use through real-world evidence.
The doctoral program encompasses a blend of coursework, comprehensive examinations, and supervised research.
Note: The specific selection and sequence of courses may vary based on students’ prior training and chosen research topics, guided by their supervisor and program committee.
Prospective students typically need to demonstrate a strong academic background, often requiring a minimum GPA for admission. Additionally, proficiency in English is essential, with standardized tests such as the TOEFL iBT or equivalent commonly accepted.
Graduates of the PhD program in Epidemiology - Pharmacoepidemiology can pursue diverse career paths in academia, public health, pharmaceuticals, and governmental organizations. They are well-equipped to undertake roles in research, policy development, and health program evaluation, contributing significantly to the understanding and improvement of drug safety and efficacy in populations.
Shortlist scholarships and plan your application — free guidance from our advisors.